Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Congenital Muscle Disease Patient and Proxy Reported Outcome Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01403402
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:04.362792+00:00
Published At
2021-08-09T00:00:00+00:00
Record Updated At
2021-08-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency", "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)", "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations)", "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan)", "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy)", "Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))", "Alpha-Dystroglycanopathy (Fukuyama CMD)", "Alpha-Dystroglycanopathy (LGMDR09 FKRP Related (Formerly LGMD2I))", "Alpha-Dystroglycanopathy (LGMDR11 POMT1 Related (Formerly LGMD2K))", "Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M))", "Alpha-Dystroglycanopathy (LGMDR14 POMT2 Related (Formerly LGMD2N))", "Alpha-Dystroglycanopathy (LGMDR15 POMGnT1 Related (Formerly LGMD2O))", "Alpha-Dystroglycanopathy (LGMDR19 GMPPB Related (Formerly LGMD2T))", "Alpha-Dystroglycanopathy (LGMDR20 ISPD Related (Formerly LGMD2U))", "Alpha-Dystroglycanopathy (LGMDR24 POMGnT2 Related)", "Alpha-Dystroglycanopathy (Muscle Eye Brain Disease (MEB))", "Alpha-Dystroglycanopathy (Walker Warburg Syndrome (WWS))", "Choline Kinase B Receptor - CHKB", "Collagen VI Related Disorders", "Collagen XII Related Disorders", "Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive)", "Congenital Muscular Dystrophy With Cataracts and Intellectual Disability (MDCCAID)", "Congenital Muscular Dystrophy With Joint Hyperlaxity", "Congenital Muscular Dystrophy With Rigid Spine Related to ACTA1", "Emery-Dreifuss Muscular Dystrophy", "GOLGA2-related Congenital Muscle Dystrophy With Brain Involvement", "LMNA Related Disorders", "Merosin Deficient CMD (Full or Partial)", "Nesprin Related MD (SYNE1)", "SELENON Related Disorders (Previously Known as SEPN1)", "SELENON Related Myopathy (Aka SEPN1)", "Telethonin CMD", "Congenital Myasthenic Syndrome", "Limb-Girdle Muscular Dystrophy", "LGMDD01 - DNAJB6 (Formerly LGMD1D)", "LGMDD05 - Collagen VI Related Bethlem Myopathy (Dominant)", "LGMDR07 - Telethonin (TCAP) Related (Formerly LGMD2G)", "LGMDR08 - TRIM Related (Formerly LGMD2H)", "LGMDR09 - FKRP Related (Formerly LGMD2I)", "LGMDR10 - Titin (TTN) Related (Formerly LGMD2J)", "LGMDR11 - POMT1 Related (Formerly LGMD2K)", "LGMDR13 - Fukutin (FKTN) Related (Formerly LGMD2M)", "LGMDR14 - POMT2 Related (Formerly LGMD2N)", "LGMDR15 - POMGnT1 Related (Formerly LGMD2O)", "LGMDR16 - DAG1 Related Dystroglycanopathy (Formerly LGMD2P)", "LGMDR17 - Plectin (PLEC) Related (Formerly LGMD2Q)", "LGMDR18 - TRAPPC11 Related (Formerly LGMD2S)", "LGMDR19 - GMPPB Related (Formerly LGMD2T)", "LGMDR20 - ISPD Related (Formerly LGMD2U)", "LGMDR22 - Collagen VI Related Bethlem Myopathy (Recessive)", "LGMDR23 - LAMA2 Related", "LGMDR24 - POMGnT2 Related"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-08-09"
protocolSection.identificationModule.nctId
"NCT01403402"
protocolSection.identificationModule.officialTitle
"Congenital Muscle Disease Patient and Proxy Reported Outcome Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (Fukuyama CMD) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (LGMDR09 FKRP Related (Formerly LGMD2I)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (LGMDR11 POMT1 Related (Formerly LGMD2K)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (LGMDR14 POMT2 Related (Formerly LGMD2N)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (LGMDR15 POMGnT1 Related (Formerly LGMD2O)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (LGMDR19 GMPPB Related (Formerly LGMD2T)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (LGMDR20 ISPD Related (Formerly LGMD2U)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (LGMDR24 POMGnT2 Related) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (Muscle Eye Brain Disease (MEB)) (protocolSection.conditionsModule.conditions)
  • Alpha-Dystroglycanopathy (Walker Warburg Syndrome (WWS)) (protocolSection.conditionsModule.conditions)
  • Choline Kinase B Receptor - CHKB (protocolSection.conditionsModule.conditions)
  • Collagen VI Related Disorders (protocolSection.conditionsModule.conditions)
  • Collagen XII Related Disorders (protocolSection.conditionsModule.conditions)
  • Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive) (protocolSection.conditionsModule.conditions)
  • Congenital Muscular Dystrophy With Cataracts and Intellectual Disability (MDCCAID) (protocolSection.conditionsModule.conditions)
  • Congenital Muscular Dystrophy With Joint Hyperlaxity (protocolSection.conditionsModule.conditions)
  • Congenital Muscular Dystrophy With Rigid Spine Related to ACTA1 (protocolSection.conditionsModule.conditions)
  • Emery-Dreifuss Muscular Dystrophy (protocolSection.conditionsModule.conditions)
  • GOLGA2-related Congenital Muscle Dystrophy With Brain Involvement (protocolSection.conditionsModule.conditions)
  • LMNA Related Disorders (protocolSection.conditionsModule.conditions)
  • Merosin Deficient CMD (Full or Partial) (protocolSection.conditionsModule.conditions)
  • Nesprin Related MD (SYNE1) (protocolSection.conditionsModule.conditions)
  • SELENON Related Disorders (Previously Known as SEPN1) (protocolSection.conditionsModule.conditions)
  • SELENON Related Myopathy (Aka SEPN1) (protocolSection.conditionsModule.conditions)
  • Telethonin CMD (protocolSection.conditionsModule.conditions)
  • Congenital Myasthenic Syndrome (protocolSection.conditionsModule.conditions)
  • Limb-Girdle Muscular Dystrophy (protocolSection.conditionsModule.conditions)
  • LGMDD01 - DNAJB6 (Formerly LGMD1D) (protocolSection.conditionsModule.conditions)
  • LGMDD05 - Collagen VI Related Bethlem Myopathy (Dominant) (protocolSection.conditionsModule.conditions)
  • LGMDR07 - Telethonin (TCAP) Related (Formerly LGMD2G) (protocolSection.conditionsModule.conditions)
  • LGMDR08 - TRIM Related (Formerly LGMD2H) (protocolSection.conditionsModule.conditions)
  • LGMDR09 - FKRP Related (Formerly LGMD2I) (protocolSection.conditionsModule.conditions)
  • LGMDR10 - Titin (TTN) Related (Formerly LGMD2J) (protocolSection.conditionsModule.conditions)
  • LGMDR11 - POMT1 Related (Formerly LGMD2K) (protocolSection.conditionsModule.conditions)
  • LGMDR13 - Fukutin (FKTN) Related (Formerly LGMD2M) (protocolSection.conditionsModule.conditions)
  • LGMDR14 - POMT2 Related (Formerly LGMD2N) (protocolSection.conditionsModule.conditions)
  • LGMDR15 - POMGnT1 Related (Formerly LGMD2O) (protocolSection.conditionsModule.conditions)
  • LGMDR16 - DAG1 Related Dystroglycanopathy (Formerly LGMD2P) (protocolSection.conditionsModule.conditions)
  • LGMDR17 - Plectin (PLEC) Related (Formerly LGMD2Q) (protocolSection.conditionsModule.conditions)
  • LGMDR18 - TRAPPC11 Related (Formerly LGMD2S) (protocolSection.conditionsModule.conditions)
  • LGMDR19 - GMPPB Related (Formerly LGMD2T) (protocolSection.conditionsModule.conditions)
  • LGMDR20 - ISPD Related (Formerly LGMD2U) (protocolSection.conditionsModule.conditions)
  • LGMDR22 - Collagen VI Related Bethlem Myopathy (Recessive) (protocolSection.conditionsModule.conditions)
  • LGMDR23 - LAMA2 Related (protocolSection.conditionsModule.conditions)
  • LGMDR24 - POMGnT2 Related (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.